The U.S. Trade Representative announced a tariff investigation into Germany's plan to cut spending on medicines, calling the move a "serious step backwards." The probe could lead to new duties on pharmaceutical imports from Germany.
Impact: Potential tariffs may increase costs for U.S. drug manufacturers that rely on German imports, pressuring margins.
Not investment advice